In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colibri Heart Valve LLC

http://colibrihv.com/

Latest From Colibri Heart Valve LLC

Coronavirus Update: EMA To Update Comirnaty And Spikevax Labels On Cardiac Safety

Comirnaty and Spikevax to get EU label update on cardiac safety, Japanese filing for REGEN-COV, plus vaccine progress for ReiThera and Genexine.

Coronavirus COVID-19 Vaccines

Coronavirus Notebook: Vaccine Shortage Fears Heightened By Safety Scares, Italian Jab Enters Phase II/III

Russia’s Sputnik V vaccine gets the all-clear in India as the COVAX initiative hits the shortages speed bump. Also, two more antibody treatments are OKd for use in COVID-19 in the UK.

Europe United Kingdom

Coronavirus Update: Double-Mutant Strain Discovered, India Puts Temporary Hold On AZ Vaccine Exports

Concern in India as a double-mutant strain with E484Q and L452R escape mutations has been found in the state of Maharashtra.

Coronavirus COVID-19 Clinical Trials

China's Venus Persists With Global TAVR Solutions Expansion

Venus Medtech, the Chinese transcatheter aortic valve technology specialist, has made its second international acquisition as it pursues its strategy for global expansion in the TAVR market.

Commercial Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
  • Other Names / Subsidiaries
    • Colibri Heart Valve, LLC
    • Colibri/Venus Joint Venture Entity
UsernamePublicRestriction

Register